Search alternatives:
adoptive » adaptive (Expand Search)
Showing 1 - 20 results of 622 for search 'adoptive (cell OR well) transfer*', query time: 0.63s Refine Results
  1. 1
  2. 2

    Regional and intratumoral adoptive T-cell therapy by I. Olivera, I. Etxeberria, C. Luri-Rey, P. Molero-Glez, I. Melero

    Published 2024-12-01
    “…Building upon the experience of regional administration in other immunotherapies, the regional administration of adoptive cell therapies is being assessed to overcome this challenge, granting a first round of access of the transferred T cells to the tumor niche and thereby ensuring their activation and expansion. …”
    Get full text
    Article
  3. 3

    ADOPTIVE CELL THERAPY: CURRENT ADVANCES by T. V. Shamova, A. O. Sitkovskaya, L. N. Vashchenko, E. E. Kechedzhieva

    Published 2020-03-01
    “…The main part of the article provides information on the mechanisms of adoptive T cell (unmodified and genetically modified) transfer, the creation of dendritic cell vaccines and cytokine-induced killers (CIK). …”
    Get full text
    Article
  4. 4

    Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients by Abdulaziz Alamri

    Published 2025-02-01
    “…Therapeutic strategies include adoptive transfer, cytokine modulation, and optimized delivery. …”
    Get full text
    Article
  5. 5

    Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy by Gregory B. Lesinski, Chrystal M. Paulos, Maggie Phillips, Jacklyn Hammons, Isaac Karpovsky, Zaid Mahdi, Natalie K. Horvat, Megan M. Wyatt, Margaret A. Hall, Cameron J. Herting, Richard A. Moffitt

    Published 2024-01-01
    “…These models shall serve an indepth study of how to overcome barriers that limit antitumor activity of adoptively transferred T cells.…”
    Get full text
    Article
  6. 6
  7. 7

    Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy by Larissa A. Pikor, Sindhu Arivazhagan, Michael Mendicino, Sarmitha Sathiamoorthy

    Published 2025-07-01
    “…Adoptive transfer of Tregs for the treatment of autoimmune disorders such as arthritis and allergic airway inflammation, graft-versus-host disease (GvHD) and rejection following transplant have shown promise in early phase clinical trials. …”
    Get full text
    Article
  8. 8

    Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling. by Rinat Sharir, Jonathan Semo, Sara Shimoni, Tamar Ben-Mordechai, Natalie Landa-Rouben, Sofia Maysel-Auslender, Aviv Shaish, Michal Entin-Meer, Gad Keren, Jacob George, Jacob George

    Published 2014-01-01
    “…<h4>Conclusion</h4>Treg numbers are increased whereas their function is compromised in mice with that underwent experimental infarction. Transfer of exogeneous Tregs results in attenuation of myocardial remodeling whereas their ablation has no effect. …”
    Get full text
    Article
  9. 9

    Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis by Jie Yang, Lidong Liu, Yiming Yang, Ning Kong, Xueyu Jiang, Juan Sun, Rufeng Xie

    Published 2017-01-01
    “…Following adoptive transfer of iTregs and iTregmtDC to mice with CIA, the clinical and histopathologic scores, serum levels of IFN-γ, TNF-α, IL-17, IL-6, IL-10, TGF-β and anti-CII antibodies, and the distribution of the CD4+ Th subset were assessed. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13

    Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants by James L Gulley, Ling Zhang, Christian S Hinrichs, John S Davies, Andrew Sinkoe, Wiem Lassoued, Farrah Karimipour, Philip Homan, Daniel Burnett, Scott M Norberg, Alex Kuznetsov, Margaret Cam, Ping Xue

    Published 2024-11-01
    “…The tumor-bearing mice then underwent 5.5 Gy total body irradiation, followed by adoptive transfer of OT-I TCR-T cells engineered with or without caIL-12.Results TCR-T cells (OT-I) delivered caIL-12 to the B16-U-OVA tumor sites and induced robust tumor control and survival benefits in mice bearing a heterogeneous tumor with OVA-negative variants. caIL-12 exerted its effect on OVA-negative B16 variants primarily by priming and activating endogenous antitumor CD8 T cells via antigen spreading. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16
  17. 17

    Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells by Gregory B Lesinski, Chrystal M Paulos, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Anna C Cole, Megen C Wittling

    Published 2024-06-01
    “…Background How distinct methods of host preconditioning impact the efficacy of adoptively transferred antitumor T helper cells is unknown.Methods CD4+ T cells with a transgenic T-cell receptor that recognize tyrosinase-related peptide (TRP)-1 melanoma antigen were polarized to the T helper 17 (Th17) phenotype and then transferred into melanoma-bearing mice preconditioned with either total body irradiation or chemotherapy.Results We found that preconditioning mice with a non-myeloablative dose of total body irradiation (TBI of 5 Gy) was more effective than using an equivalently dosed non-myeloablative chemotherapy (cyclophosphamide (CTX) of 200 mg/kg) at augmenting therapeutic activity of antitumor TRP-1 Th17 cells. …”
    Get full text
    Article
  18. 18
  19. 19
  20. 20